Log In
BCIQ
Print this Print this
 

SAN-267

  Manage Alerts
Collapse Summary General Information
Company Nordic Bioscience A/S
DescriptionOral formulation of intestinal hormone glucagon-like peptide-2 (GLP-2)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOsteopetrosis
Indication DetailsTreat osteopetrosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today